search
Back to results

Cerebral Oxygen Metabolism in Children (COMIC)

Primary Purpose

Sickle Cell Disease, Cerebral Stroke

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Carbon Dioxide
Sponsored by
Washington University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Sickle Cell Disease focused on measuring extracorporeal membrane oxygenation, cerebrovascular reactivity, sickle cell disease, healthy controls, magnetic resonance imaging

Eligibility Criteria

3 Years - 50 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Healthy Controls:

  • Healthy controls ages 3-50 years of age
  • Able to participate in MRI scan without sedation
  • Not currently pregnant
  • No significant psychiatric history, defined as having a severe psychiatric diagnosis, per PI discretion
  • No history of epilepsy
  • No history of stroke or cerebrovascular disease
  • May have occasional headaches if not taking a daily preventative medication for headaches
  • Not on vasodilatory medication, such as sildenafil or verapamil

Sickle Cell Anemia Participants:

  • Ages 3-50 years of age
  • Hb SS or SBeta-thal
  • Able to participate in MRI scan without sedation
  • Not currently pregnant
  • Not on vasodilatory medication, such as sildenafil or verapamil

Extracorporeal Membrane Oxygenation (ECMO) Survivors:

  • Ages 3-50 years of age
  • History of cannulation for ECMO
  • Able to participate in MRI scan without sedation
  • Not currently pregnant
  • Not on vasodilatory medication, such as sildenafil or verapamil

Sites / Locations

  • Washington University of St. LouisRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Healthy Controls

Extracorporeal Membrane Oxygenation survivors

Sickle Cell Anemia participants

Arm Description

Outcomes

Primary Outcome Measures

Cerebral Oxygen Metabolism

Secondary Outcome Measures

Cerebrovascular Reactivity

Full Information

First Posted
November 6, 2019
Last Updated
January 27, 2023
Sponsor
Washington University School of Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT04157179
Brief Title
Cerebral Oxygen Metabolism in Children
Acronym
COMIC
Official Title
Cerebral Oxygen Metabolism in Children
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 17, 2019 (Actual)
Primary Completion Date
December 2027 (Anticipated)
Study Completion Date
December 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Washington University School of Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life. We will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to regulate blood flow based on the brain's needs. The amount of expanding and contracting the blood vessels can do varies by age. The brain's blood flow changes in small ways during everyday activities, such as normal brain growth, exercise, or deep concentration. Significant illness or psychological stress may increase the brain's metabolic demand or cause other bigger changes in blood flow. If blood vessels are not able to expand to give more blood flow when metabolic demand is high, the brain may not get all of the oxygen it needs. In extreme circumstances, if the brain is unable to get enough oxygen for a long time, a stroke may occur. Sometimes small strokes occur without other noticeable changes and are only detectable on an MRI. These are sometimes called "silent strokes." In less extreme circumstances, not having as much oxygen as it wants may cause the brain to grow and develop more slowly than it should. One way to test the ability of blood vessels to expand is by measuring blood flow while breathing in carbon dioxide. Carbon dioxide causes blood vessels in the brain to dilate without increasing brain metabolism. During this study participants may be asked to undergo a blood draw, MRI, and potential neuropsychological assessments. It is also possible that the study team will use a special mask to control the amount of carbon dioxide the participants breathe in so they don't breathe in too much.
Detailed Description
The purpose of the study is to identify imaging biomarkers for brain tissue under high metabolic stress at risk for permanent injury. We will measure CBF, OEF, and CVR in children with and without perturbations in cerebral oxygen delivery over time to determine each parameter's role in clinical and radiologic neurologic outcomes. Measuring CBF and OEF can be done with specialized MRI sequences. Measuring CVR requires a vasoactive response, such as carbon dioxide. In order to delivery carbon dioxide evenly and as safely as possible, we will use an MRI-compatible device to prevent over-breathing carbon dioxide and allow rapid steady-state physiology to minimize total scan time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sickle Cell Disease, Cerebral Stroke
Keywords
extracorporeal membrane oxygenation, cerebrovascular reactivity, sickle cell disease, healthy controls, magnetic resonance imaging

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
All arms will receive the same study conditions.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
350 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Healthy Controls
Arm Type
Active Comparator
Arm Title
Extracorporeal Membrane Oxygenation survivors
Arm Type
Active Comparator
Arm Title
Sickle Cell Anemia participants
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Carbon Dioxide
Intervention Description
Participants inhale carbon dioxide while in magnetic resonance imaging scan to measure cerebrovascular reactivity
Primary Outcome Measure Information:
Title
Cerebral Oxygen Metabolism
Time Frame
From the beginning of the MRI scan to the completion of the MRI scan -- 75 minutes.
Secondary Outcome Measure Information:
Title
Cerebrovascular Reactivity
Time Frame
From administration of carbon dioxide to end of inhalation of carbon dioxide -- 15 minutes.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Healthy Controls: Healthy controls ages 3-50 years of age Able to participate in MRI scan without sedation Not currently pregnant No significant psychiatric history, defined as having a severe psychiatric diagnosis, per PI discretion No history of epilepsy No history of stroke or cerebrovascular disease May have occasional headaches if not taking a daily preventative medication for headaches Not on vasodilatory medication, such as sildenafil or verapamil Sickle Cell Anemia Participants: Ages 3-50 years of age Hb SS or SBeta-thal Able to participate in MRI scan without sedation Not currently pregnant Not on vasodilatory medication, such as sildenafil or verapamil Extracorporeal Membrane Oxygenation (ECMO) Survivors: Ages 3-50 years of age History of cannulation for ECMO Able to participate in MRI scan without sedation Not currently pregnant Not on vasodilatory medication, such as sildenafil or verapamil
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kristin Guilliams, MD
Phone
3144546120
Email
kristinguilliams@wustl.edu
Facility Information:
Facility Name
Washington University of St. Louis
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristin Guilliams, MD
Phone
314-454-6120
Email
kristinguilliams@wustl.edu

12. IPD Sharing Statement

Learn more about this trial

Cerebral Oxygen Metabolism in Children

We'll reach out to this number within 24 hrs